Suprainguinal Fascia Iliaca Block vs. Adductor Canal Block for Analgesia After Total Knee Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-100
SponsorBursa Yuksek Ihtisas Training and Research Hospital

About this trial

This study evaluates the analgesic efficacy and motor-sparing properties of ultrasound-guided Suprainguinal Fascia Iliaca Block (S-FIB) compared with Adductor Canal Block (ACB) in patients undergoing primary total knee arthroplasty (TKA). The main hypothesis is that ACB better preserves quadriceps muscle strength, allowing earlier functional mobilization, while providing comparable (non-inferior) analgesia to S-FIB.

Eligibility criteria

Qualifiers

ASA Physical Status I, II, or III

Scheduled for elective unilateral primary total knee arthroplasty

Able to understand and operate the PCA device

Written informed consent provided

Disqualifiers

Pre-existing lower-extremity neurological deficit or motor weakness (e.g., severe diabetic neuropathy)

Chronic opioid use (>30 mg oral morphine equivalents/day for >3 months)

Infection at the block site or systemic sepsis

Coagulopathy or bleeding diathesis

Trial design

Treatments tested in this trial

  • PCA

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations